Use of oxytocin and misoprostol for induction or ... - POPPHI
Use of oxytocin and misoprostol for induction or ... - POPPHI
Use of oxytocin and misoprostol for induction or ... - POPPHI
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
105. Nigam A, Singh VK, Dubay P, P<strong>and</strong>ey K, Bhagoliwal A, Prakash A. Misoprostol<br />
vs. <strong>oxytocin</strong> <strong>f<strong>or</strong></strong> <strong>induction</strong> <strong>of</strong> lab<strong>or</strong> at term. Int J Gynaecol Obstet. 2004 Sep;86(3):398-<br />
400.<br />
106. Hemminki E, Lenck M, Saarikoski S, Henriksson L. Ambulation versus <strong>oxytocin</strong> in<br />
protracted labour: A pilot study. European Journal <strong>of</strong> Obstetrics Gynecology <strong>and</strong><br />
Reproductive Biology. 1985 [cited 11 December 2007];20(4):199-208.<br />
107. Klaus MH, Kennell JH, Robertson SS, Sosa R. Effects <strong>of</strong> social supp<strong>or</strong>t during<br />
parturition on maternal <strong>and</strong> infant m<strong>or</strong>bidity. British Medical Journal. 1986 [cited 11<br />
December 2007];293(6547):585-7.<br />
108. Boulvain M, Stan C, Irion O. Membrane sweeping <strong>f<strong>or</strong></strong> <strong>induction</strong> <strong>of</strong> labour. Cochrane<br />
database <strong>of</strong> systematic reviews (Online). 2005 [cited 26 November 2007](1).<br />
109. Boulvain M, Kelly A, Lohse C, Stan C, Irion O. Mechanical methods <strong>f<strong>or</strong></strong> <strong>induction</strong><br />
<strong>of</strong> labour. Cochrane database <strong>of</strong> systematic reviews (Online : Update S<strong>of</strong>tware). 2001<br />
[cited 16 October 2007](4).<br />
110. Smyth RM, Alldred SK, Markham C. Amniotomy <strong>f<strong>or</strong></strong> sh<strong>or</strong>tening spontaneous<br />
labour. Cochrane database <strong>of</strong> systematic reviews (Online). 2007 [cited 27 February<br />
2008](4).<br />
111. Lyall EGH, Blott M, De Ruiter A, Hawkins D, Mercy D, Mitchla Z, et al.<br />
Guidelines <strong>f<strong>or</strong></strong> the management <strong>of</strong> HIV infection in pregnant women <strong>and</strong> the prevention<br />
<strong>of</strong> mother-to-child transmission. HIV Medicine. 2001 [cited 27 February 2008];2(4):314-<br />
34.<br />
112. W<strong>or</strong>ld Health Organization. WHO pharmaceuticals newsletter no. 3 . 2002.<br />
113. Weeks AD, Fiala C, Safar P. Misoprostol <strong>and</strong> the debate over <strong>of</strong>f-label drug use.<br />
BJOG. 2005 Mar;112(3):269-72.<br />
114. Misoprostol.<strong>or</strong>g [homepage on the Internet]. . 2007. Available from:<br />
www.<strong>misoprostol</strong>.<strong>or</strong>g.<br />
115. Kaufman KE, Bailit JL, Grobman W. Elective <strong>induction</strong>: An analysis <strong>of</strong> economic<br />
<strong>and</strong> health consequences. American Journal <strong>of</strong> Obstetrics <strong>and</strong> Gynecology. 2002 [cited<br />
27 February 2008];187(4):858-63.<br />
116. Weeks A, Alfirevic Z. Oral <strong>misoprostol</strong> administration <strong>f<strong>or</strong></strong> lab<strong>or</strong> <strong>induction</strong>. Clinical<br />
Obstetrics <strong>and</strong> Gynecology. 2006 [cited 29 February 2008];49(3):658-71.<br />
72
Change language